Is Futarchy AMM a Good Investment?

CValue
C+Risk
|DEX
TVL$11M
FDV
TVL/FDV
Risk GradeC+
Value GradeC

Value Accrual: Does the Futarchy AMM Token Capture Value?

Futarchy AMM scores C on Hindenrank's value accrual framework (48/100), indicating average value capture — some strengths offset by weaknesses in fee distribution or sustainability. Fee capture scores 14/25 — moderate, with some fees reaching token holders but room for improvement. Token distribution is rated 12/25 (somewhat concentrated, raising concerns about governance capture), and emission sustainability sits at 12/25. The competitive moat dimension scores 10/25.

Scored as: Business
Fee Capture
14/25
Token Distribution
12/25
Emission Sustainability
12/25
Competitive Moat
10/25

Protocol Health: Is Futarchy AMM Still Growing?

Futarchy AMM's vitality risk score is 6/10 on Hindenrank's rubric (lower is healthier). This suggests moderate health — Futarchy AMM is maintaining activity but may be showing signs of plateauing growth or reduced developer engagement. The protocol is functional but may not be accelerating.

GitHub: futarchy

Risk-Adjusted View: Is the Upside Worth the Risk?

Risk-Adjusted Position

Neutral
High Value
Medium Value
Low Value
High Risk
High Risk Play
Risky
Avoid
Medium Risk
Promising
Futarchy AMM
Weak
Low Risk
Blue Chip
Safe but Stale
Dead Money
See all Neutral protocols →

Futarchy AMM sits in the Neutral zone — average on both risk (C+) and value (C). There is no strong reason to overweight or avoid the token at current levels. Monitor for catalysts that could shift the balance in either direction.

Risk Context

Futarchy AMM carries a risk grade of C+ (40/100), classified as elevated risk — multiple novel mechanisms and notable interaction risks. While no critical-severity interactions were identified, 2 high-severity interactions warrant attention. The primary risk factor is: Futarchy-based governance via conditional prediction markets is a novel and largely untested mechanism — market manipulation of thin decision markets could force bad governance outcomes

Read our full safety analysis →

Should you buy Futarchy AMM?

Futarchy AMM scores C on Hindenrank's value accrual framework, placing it among the average DEX protocols. Fee capture scores 14/25 — moderate, with some fees reaching token holders but room for improvement. Token distribution is somewhat concentrated, raising concerns about governance capture, and emission sustainability sits at 12/25. On the risk side, Futarchy AMM carries a C+ grade (40/100), which is elevated risk — multiple novel mechanisms and notable interaction risks. The combined risk-value position places Futarchy AMM in the Neutral quadrant.

Futarchy AMM investment outlook for 2026

With $11M in total value locked, Futarchy AMM's fundamentals do not strongly support the current valuation from a usage perspective. The competitive moat dimension scores 10/25, suggesting limited moat, leaving the protocol vulnerable to competitive pressure.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.

This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology

Weekly Commentary

Pro

Week of March 3, 2026

Futarchy AMM sits squarely in no-man's-land — a C+ risk grade and C value score mean you're taking mid-tier risk for mid-tier token economics, with only $13M in TVL to show for it. The prediction-market-based pricing mechanism is intellectually interesting but unproven at scale, and the thin liquidity amplifies every interaction risk the rubric flags. Until either the risk profile tightens or value accrual gives holders a reason to stay, there are better places to park capital in the DEX sector.

Related DEX Investment Analyses

Related DEX Safety Analyses

Investment analysis uses Hindenrank's value accrual framework across four dimensions: fee capture, token distribution, emission sustainability, and competitive moat. Higher score = better value accrual. Combined with our eight-dimension risk rubric for risk-adjusted positioning. This is not financial advice.